Status:
COMPLETED
Periodic Use of Continuous Glucose Monitoring With Personalized Diet Interventions Using AI Camera Among Non-insulin Treated Type 2 Diabetes
Lead Sponsor:
Kangbuk Samsung Hospital
Collaborating Sponsors:
Daewoong Pharmaceutical Co. LTD.
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the periodic use of continuous glucose monitoring (CGM) with an AI camera and following diet education among non-insulin-treated type 2 diabetes patients.
Detailed Description
The control group used self-monitoring blood glucose (SMBG) for two weeks with a manual food diary followed by diet education and repeated SMBG with a food diary three months later. Treatment 1 group ...
Eligibility Criteria
Inclusion
- Type 2 diabetes patients
- HbA1c 6.5% - 10%
- No medication changes in the past 3 months, and receiving treatment with lifestyle modification or oral antidiabetic drugs or GLP-1 receptor agonists
- Ages 18 - 80 years old
Exclusion
- Insulin users
- Those who have used steroids within the past 3 months or are expected to use them during the study period (excluding ointments)
- Type 1 diabetes patients
- Patients who have undergone pancreatic resection
- Patients undergoing hemodialysis or peritoneal dialysis
- Those requiring continuous MRI and CT scans
- Those deemed by the researcher to have difficulty handling continuous glucose monitors and AI cameras
- Those deemed unsuitable for participation in this clinical trial by the investigator, other than those mentioned above
- Pregnant women
Key Trial Info
Start Date :
April 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06594055
Start Date
April 4 2023
End Date
October 31 2024
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kangbuksamsung Hospital
Seoul, South Korea, 00000